Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYJournal of healthcare informatics research

Generative Language Models for Disease Treatment Recommendations: A Systematic Literature Review

  1. 1Recife, PE Brazil

Abstract

The rapid evolution of Generative Artificial Intelligence (GenAI) presents significant opportunities to transform healthcare, particularly in generating personalized treatment recommendations. This systematic literature review explores the current state of GenAI language models applications in various medical domains, assessing their effectiveness, applicability, and limitations. The review addresses nine specific research questions to understand the potential and challenges of integrating GenAI into clinical practice. We use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. From a pool of 3237 studies, 42 were selected based on inclusion and exclusion criteria. These studies were analyzed to evaluate the use of generative language models, such as GPT-3 and GPT-4, in various medical domains including oncology, cardiovascular, gastrointestinal, and ophthalmological care. The analysis revealed that most GenAI applications in healthcare rely on general purpose LLMs to provide treatment recommendations. Fine-tuning with domain-specific data and prompt engineering were found to significantly improve output quality and reliability. However, persistent challenges include lack of clinical validation, ethical concerns such as bias, and issues related to transparency and regulatory compliance. While GenAI demonstrates strong potential to support clinical decision-making, real-world deployment remains limited due to unresolved ethical and validation issues. Future research should prioritize the development of interpretable, domain-specific models and rigorous clinical trials to ensure safe and effective integration into healthcare settings.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s41666-026-00242-y.

Related

  1. Silent Manipulation of Mental Health Treatment Recommendations From a Large Language Model
    Roy H. Perlis
    JAMA Network OpenPeer-reviewedCC BY 4.0General medicineCrossref
  2. Title and abstract screening for systematic reviews with Jev, a System One model: comparison with generative large language models
    K. Matsui, Y. Takaesu
    medRxivPreprintCC BYFull text1 citedEpidemiology & public healthmedRxiv
  3. Pregnancy testing prior to iodine-131 thyroid therapy: a literature review of current recommendations
    Stephen J. Sozio, David Cohen, William Y. Raynor +1
    EJNMMI reportsPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  4. Hyperdominant Left Circumflex Artery Challenging Conventional Paradigms and Current Guideline Recommendations: A Comprehensive Literature Review and Case Series
    Amirmahdi Mohammadi, Mohammad Sadegh‐Vashveshady
    Clinical case reportsPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  5. Effectiveness of a Molecular Tumor Board in Making Personalized Treatment Recommendations for Patients with Advanced Cancer
    A. Rose, M. Basik, c. ferrario +15
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
BibTeX
@article{neto2026generative,
  title = {{Generative Language Models for Disease Treatment Recommendations: A Systematic Literature Review}},
  author = {Leonides Medeiros Neto and Maicon Herverton Lino Ferreira da Silva Barros and Kayo Henrique de Carvalho Monteiro and Estefani Pontes Simão and Sebastião Rogério da Silva Neto and Luis Filipe Silva de Vasconcelos and João Pedro Pimenta and Iago Richard Rodrigues and Patricia Takako Endo},
  journal = {Journal of healthcare informatics research},
  year = {2026},
  month = aug,
  doi = {10.1007/s41666-026-00242-y},
  url = {https://europepmc.org/article/PMC/PMC13719915},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Generative Language Models for Disease Treatment Recommendations: A Systematic Literature Review
AU  - Leonides Medeiros Neto
AU  - Maicon Herverton Lino Ferreira da Silva Barros
AU  - Kayo Henrique de Carvalho Monteiro
AU  - Estefani Pontes Simão
AU  - Sebastião Rogério da Silva Neto
AU  - Luis Filipe Silva de Vasconcelos
AU  - João Pedro Pimenta
AU  - Iago Richard Rodrigues
AU  - Patricia Takako Endo
PY  - 2026
DA  - 2026/08/03
JO  - Journal of healthcare informatics research
DO  - 10.1007/s41666-026-00242-y
UR  - https://europepmc.org/article/PMC/PMC13719915
AB  - The rapid evolution of Generative Artificial Intelligence (GenAI) presents significant opportunities to transform healthcare, particularly in generating personalized treatment recommendations. This systematic literature review explores the current state of GenAI language models applications in various medical domains, assessing their effectiveness, applicability, and limitations. The review addresses nine specific research questions to understand the potential and challenges of integrating GenAI into clinical practice. We use the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. From a pool of 3237 studies, 42 were selected based on inclusion and exclusion criteria. These studies were analyzed to evaluate the use of generative language models, such as GPT-3 and GPT-4, in various medical domains including oncology, cardiovascular, gastrointestinal, and ophthalmological care. The analysis revealed that most GenAI applications in healthcare rely on general purpose LLMs to provide treatment recommendations. Fine-tuning with domain-specific data and prompt engineering were found to significantly improve output quality and reliability. However, persistent challenges include lack of clinical validation, ethical concerns such as bias, and issues related to transparency and regulatory compliance. While GenAI demonstrates strong potential to support clinical decision-making, real-world deployment remains limited due to unresolved ethical and validation issues. Future research should prioritize the development of interpretable, domain-specific models and rigorous clinical trials to ensure safe and effective integration into healthcare settings.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s41666-026-00242-y.
SN  - 2509-4971
SN  - 2509-498X
ER  -